nodes	percent_of_prediction	percent_of_DWPC	metapath
Phylloquinone—BGLAP—leg—multiple sclerosis	0.192	0.696	CbGeAlD
Phylloquinone—Atrophy—Prednisolone—multiple sclerosis	0.0295	0.0427	CcSEcCtD
Phylloquinone—Atrophy—Triamcinolone—multiple sclerosis	0.0271	0.0392	CcSEcCtD
Phylloquinone—Atrophy—Methylprednisolone—multiple sclerosis	0.0271	0.0392	CcSEcCtD
Phylloquinone—Atrophy—Betamethasone—multiple sclerosis	0.0246	0.0356	CcSEcCtD
Phylloquinone—Atrophy—Dexamethasone—multiple sclerosis	0.0246	0.0356	CcSEcCtD
Phylloquinone—GGCX—nervous system—multiple sclerosis	0.0229	0.0829	CbGeAlD
Phylloquinone—GGCX—central nervous system—multiple sclerosis	0.0221	0.0799	CbGeAlD
Phylloquinone—GGCX—cerebellum—multiple sclerosis	0.0216	0.0781	CbGeAlD
Phylloquinone—Atrophy—Prednisone—multiple sclerosis	0.0214	0.031	CcSEcCtD
Phylloquinone—Inflammation—Cladribine—multiple sclerosis	0.0184	0.0266	CcSEcCtD
Phylloquinone—Injection site reaction—Cladribine—multiple sclerosis	0.0177	0.0256	CcSEcCtD
Phylloquinone—GGCX—brain—multiple sclerosis	0.0175	0.0634	CbGeAlD
Phylloquinone—Phlebitis—Cladribine—multiple sclerosis	0.015	0.0217	CcSEcCtD
Phylloquinone—Necrosis—Mitoxantrone—multiple sclerosis	0.0149	0.0216	CcSEcCtD
Phylloquinone—Swelling—Cladribine—multiple sclerosis	0.0147	0.0212	CcSEcCtD
Phylloquinone—Necrosis—Methylprednisolone—multiple sclerosis	0.0112	0.0163	CcSEcCtD
Phylloquinone—Sweating increased—Cladribine—multiple sclerosis	0.0109	0.0158	CcSEcCtD
Phylloquinone—Hypotension—Fingolimod—multiple sclerosis	0.0105	0.0152	CcSEcCtD
Phylloquinone—Necrosis—Betamethasone—multiple sclerosis	0.0102	0.0148	CcSEcCtD
Phylloquinone—Necrosis—Dexamethasone—multiple sclerosis	0.0102	0.0148	CcSEcCtD
Phylloquinone—Dyspnoea—Fingolimod—multiple sclerosis	0.01	0.0145	CcSEcCtD
Phylloquinone—Phlebitis—Mitoxantrone—multiple sclerosis	0.00987	0.0143	CcSEcCtD
Phylloquinone—Swelling—Mitoxantrone—multiple sclerosis	0.00964	0.014	CcSEcCtD
Phylloquinone—Inflammation—Methylprednisolone—multiple sclerosis	0.00909	0.0132	CcSEcCtD
Phylloquinone—Necrosis—Prednisone—multiple sclerosis	0.0089	0.0129	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.00878	0.0127	CcSEcCtD
Phylloquinone—Cyanosis—Methotrexate—multiple sclerosis	0.00824	0.0119	CcSEcCtD
Phylloquinone—Immune system disorder—Cladribine—multiple sclerosis	0.00808	0.0117	CcSEcCtD
Phylloquinone—Erythema—Cladribine—multiple sclerosis	0.00779	0.0113	CcSEcCtD
Phylloquinone—Necrosis—Methotrexate—multiple sclerosis	0.00743	0.0108	CcSEcCtD
Phylloquinone—Dizziness—Fingolimod—multiple sclerosis	0.00742	0.0107	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.00721	0.0104	CcSEcCtD
Phylloquinone—Sweating increased—Mitoxantrone—multiple sclerosis	0.00716	0.0104	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.00663	0.00959	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.00661	0.00957	CcSEcCtD
Phylloquinone—Immune system disorder—Azathioprine—multiple sclerosis	0.00657	0.00951	CcSEcCtD
Phylloquinone—Hyperbilirubinaemia—Methotrexate—multiple sclerosis	0.00642	0.00929	CcSEcCtD
Phylloquinone—Sweating—Mitoxantrone—multiple sclerosis	0.00628	0.00909	CcSEcCtD
Phylloquinone—Hyperhidrosis—Cladribine—multiple sclerosis	0.00615	0.0089	CcSEcCtD
Phylloquinone—Inflammation—Methotrexate—multiple sclerosis	0.00602	0.00871	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.00601	0.0087	CcSEcCtD
Phylloquinone—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.00601	0.0087	CcSEcCtD
Phylloquinone—Hypotension—Cladribine—multiple sclerosis	0.00594	0.0086	CcSEcCtD
Phylloquinone—Sweating increased—Prednisolone—multiple sclerosis	0.00587	0.0085	CcSEcCtD
Phylloquinone—Dyspnoea—Cladribine—multiple sclerosis	0.00567	0.0082	CcSEcCtD
Phylloquinone—Pain—Cladribine—multiple sclerosis	0.00544	0.00787	CcSEcCtD
Phylloquinone—Sweating increased—Triamcinolone—multiple sclerosis	0.0054	0.00782	CcSEcCtD
Phylloquinone—Sweating increased—Methylprednisolone—multiple sclerosis	0.00539	0.0078	CcSEcCtD
Phylloquinone—Erythema—Mitoxantrone—multiple sclerosis	0.00512	0.00741	CcSEcCtD
Phylloquinone—Sweating increased—Betamethasone—multiple sclerosis	0.0049	0.00709	CcSEcCtD
Phylloquinone—Sweating increased—Dexamethasone—multiple sclerosis	0.0049	0.00709	CcSEcCtD
Phylloquinone—Hypotension—Azathioprine—multiple sclerosis	0.00483	0.00699	CcSEcCtD
Phylloquinone—Sweating—Methylprednisolone—multiple sclerosis	0.00473	0.00684	CcSEcCtD
Phylloquinone—Hypersensitivity—Cladribine—multiple sclerosis	0.00468	0.00678	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	0.00446	0.136	CbGpPWpGaD
Phylloquinone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.00438	0.00634	CcSEcCtD
Phylloquinone—Sweating increased—Prednisone—multiple sclerosis	0.00427	0.00618	CcSEcCtD
Phylloquinone—Dizziness—Cladribine—multiple sclerosis	0.0042	0.00609	CcSEcCtD
Phylloquinone—Erythema—Prednisolone—multiple sclerosis	0.0042	0.00608	CcSEcCtD
Phylloquinone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00418	0.00605	CcSEcCtD
Phylloquinone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00404	0.00585	CcSEcCtD
Phylloquinone—Immune system disorder—Methylprednisolone—multiple sclerosis	0.004	0.00579	CcSEcCtD
Phylloquinone—Hypotension—Mitoxantrone—multiple sclerosis	0.0039	0.00565	CcSEcCtD
Phylloquinone—Erythema—Triamcinolone—multiple sclerosis	0.00386	0.00559	CcSEcCtD
Phylloquinone—Erythema—Methylprednisolone—multiple sclerosis	0.00385	0.00558	CcSEcCtD
Phylloquinone—Hypersensitivity—Azathioprine—multiple sclerosis	0.00381	0.00551	CcSEcCtD
Phylloquinone—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00373	0.00539	CcSEcCtD
Phylloquinone—Pain—Mitoxantrone—multiple sclerosis	0.00357	0.00517	CcSEcCtD
Phylloquinone—Erythema—Betamethasone—multiple sclerosis	0.0035	0.00507	CcSEcCtD
Phylloquinone—Erythema—Dexamethasone—multiple sclerosis	0.0035	0.00507	CcSEcCtD
Phylloquinone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00343	0.00496	CcSEcCtD
Phylloquinone—Dizziness—Azathioprine—multiple sclerosis	0.00342	0.00495	CcSEcCtD
Phylloquinone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00331	0.0048	CcSEcCtD
Phylloquinone—Flushing—Prednisone—multiple sclerosis	0.00325	0.00471	CcSEcCtD
Phylloquinone—Immune system disorder—Prednisone—multiple sclerosis	0.00317	0.00458	CcSEcCtD
Phylloquinone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00315	0.00456	CcSEcCtD
Phylloquinone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00315	0.00455	CcSEcCtD
Phylloquinone—Sweating—Methotrexate—multiple sclerosis	0.00313	0.00453	CcSEcCtD
Phylloquinone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00308	0.00446	CcSEcCtD
Phylloquinone—Erythema—Prednisone—multiple sclerosis	0.00305	0.00442	CcSEcCtD
Phylloquinone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00305	0.00441	CcSEcCtD
Phylloquinone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00304	0.0044	CcSEcCtD
Phylloquinone—Hypotension—Methylprednisolone—multiple sclerosis	0.00294	0.00425	CcSEcCtD
Phylloquinone—Pain—Prednisolone—multiple sclerosis	0.00293	0.00424	CcSEcCtD
Phylloquinone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00286	0.00414	CcSEcCtD
Phylloquinone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00286	0.00414	CcSEcCtD
Phylloquinone—Dyspnoea—Triamcinolone—multiple sclerosis	0.00281	0.00407	CcSEcCtD
Phylloquinone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00277	0.004	CcSEcCtD
Phylloquinone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00277	0.004	CcSEcCtD
Phylloquinone—Pain—Triamcinolone—multiple sclerosis	0.0027	0.0039	CcSEcCtD
Phylloquinone—Hypotension—Dexamethasone—multiple sclerosis	0.00267	0.00387	CcSEcCtD
Phylloquinone—Hypotension—Betamethasone—multiple sclerosis	0.00267	0.00387	CcSEcCtD
Phylloquinone—Immune system disorder—Methotrexate—multiple sclerosis	0.00265	0.00383	CcSEcCtD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	0.00256	0.0782	CbGpPWpGaD
Phylloquinone—Erythema—Methotrexate—multiple sclerosis	0.00255	0.00369	CcSEcCtD
Phylloquinone—Hypersensitivity—Prednisolone—multiple sclerosis	0.00253	0.00366	CcSEcCtD
Phylloquinone—Anaphylactic shock—Prednisone—multiple sclerosis	0.00249	0.00361	CcSEcCtD
Phylloquinone—Pain—Dexamethasone—multiple sclerosis	0.00245	0.00354	CcSEcCtD
Phylloquinone—Pain—Betamethasone—multiple sclerosis	0.00245	0.00354	CcSEcCtD
Phylloquinone—Hyperhidrosis—Prednisone—multiple sclerosis	0.00241	0.00349	CcSEcCtD
Phylloquinone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00232	0.00336	CcSEcCtD
Phylloquinone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00232	0.00335	CcSEcCtD
Phylloquinone—Dizziness—Prednisolone—multiple sclerosis	0.00227	0.00328	CcSEcCtD
Phylloquinone—Dizziness—Triamcinolone—multiple sclerosis	0.00208	0.00302	CcSEcCtD
Phylloquinone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00208	0.00301	CcSEcCtD
Phylloquinone—Dizziness—Methylprednisolone—multiple sclerosis	0.00208	0.00301	CcSEcCtD
Phylloquinone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00201	0.00291	CcSEcCtD
Phylloquinone—Hypotension—Methotrexate—multiple sclerosis	0.00195	0.00282	CcSEcCtD
Phylloquinone—Dizziness—Dexamethasone—multiple sclerosis	0.00189	0.00274	CcSEcCtD
Phylloquinone—Dizziness—Betamethasone—multiple sclerosis	0.00189	0.00274	CcSEcCtD
Phylloquinone—Dyspnoea—Methotrexate—multiple sclerosis	0.00186	0.00269	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—multiple sclerosis	0.00186	0.0566	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—SPP1—multiple sclerosis	0.00184	0.0563	CbGpPWpGaD
Phylloquinone—Hypersensitivity—Prednisone—multiple sclerosis	0.00184	0.00266	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—ICAM1—multiple sclerosis	0.00181	0.0551	CbGpPWpGaD
Phylloquinone—Pain—Methotrexate—multiple sclerosis	0.00178	0.00258	CcSEcCtD
Phylloquinone—Dizziness—Prednisone—multiple sclerosis	0.00165	0.00238	CcSEcCtD
Phylloquinone—Hypersensitivity—Methotrexate—multiple sclerosis	0.00153	0.00222	CcSEcCtD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—TYK2—multiple sclerosis	0.00147	0.0448	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	0.00138	0.0422	CbGpPWpGaD
Phylloquinone—Dizziness—Methotrexate—multiple sclerosis	0.00138	0.00199	CcSEcCtD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—multiple sclerosis	0.00133	0.0405	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—CD4—multiple sclerosis	0.00126	0.0384	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	0.0011	0.0335	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—STAT3—multiple sclerosis	0.00103	0.0314	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	0.001	0.0306	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—MMP9—multiple sclerosis	0.000981	0.0299	CbGpPWpGaD
Phylloquinone—BGLAP—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	0.000974	0.0297	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—TGFB1—multiple sclerosis	0.000952	0.0291	CbGpPWpGaD
Phylloquinone—BGLAP—Interleukin-11 Signaling Pathway—MAPK1—multiple sclerosis	0.000934	0.0285	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—STAT3—multiple sclerosis	0.000872	0.0266	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	0.000835	0.0255	CbGpPWpGaD
Phylloquinone—BGLAP—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—multiple sclerosis	0.000824	0.0252	CbGpPWpGaD
Phylloquinone—BGLAP—FGF signaling pathway—MAPK1—multiple sclerosis	0.000793	0.0242	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—SLC30A7—multiple sclerosis	0.000763	0.0233	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	0.000742	0.0226	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—PABPC1—multiple sclerosis	0.000617	0.0188	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	0.000567	0.0173	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—RPL5—multiple sclerosis	0.000557	0.017	CbGpPWpGaD
Phylloquinone—BGLAP—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	0.000436	0.0133	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—BCHE—multiple sclerosis	0.000407	0.0124	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—POMC—multiple sclerosis	0.000211	0.00643	CbGpPWpGaD
Phylloquinone—GGCX—Metabolism of proteins—CCL2—multiple sclerosis	0.000206	0.00629	CbGpPWpGaD
